PD-L1 and IAPs Co-Operate to Protect Tumors From Cytotoxic Lymphocyte-Derived TNF

Cell Death and Differentiation - United Kingdom
doi 10.1038/cdd.2017.94
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The PD-1/PD-L1 (B7-H1) Pathway in Chronic Infection-Induced Cytotoxic T Lymphocyte Exhaustion

Journal of Biomedicine and Biotechnology
2011English

PD-L1 Expression in Inflammatory Myofibroblastic Tumors

Modern Pathology
Forensic MedicinePathology
2018English

Microparticles From Tumors Exposed to Radiation Promote Immune Evasion in Part by PD-L1

Oncogene
Cancer ResearchGeneticsMolecular Biology
2019English

P2.01-82 Neutrophil-To-Lymphocyte Ratio Complements the Prognostic Ability of PD-L1 in Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

IAPs Protect Host Target Tissues From Graft-Versus-Host Disease in Mice

Blood advances
Hematology
2017English

P3.12-05 the Pattern of PD-L1 Expression in Thoracic Neuroendocrine Tumors

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Reply to ‘Challenging PD-L1 Expressing Cytotoxic T Cells as a Predictor for Response to Immunotherapy in Melanoma’

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2018English

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

Breast Care
SurgeryOncology
2016English

Immune Profiling of Malignant Pleural Mesothelioma by Flow Cytometry Identifies Distinct T-Cell Activation and Exhaustion Phenotypes in PD-L1 Positive Versus PD-L1 Negative Tumors

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy